OAK HILL BIO LTD
Get an alert when OAK HILL BIO LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-14 (in 6mo)
Last made up 2025-10-31
Watchouts
Cash
£30M
-7.9% vs 2023
Net assets
£23M
-9.9% vs 2023
Employees
7
-30% vs 2023
Profit before tax
-£3M
+43.1% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £40,633,180 | £17,382,260 | |
| Operating profit | £27,328,022 | -£1,510,528 | |
| Profit before tax | -£5,280,246 | -£3,007,060 | |
| Net profit | -£7,829,199 | -£2,580,814 | |
| Cash | £32,813,193 | £30,233,448 | |
| Total assets less current liabilities | £54,531,454 | £52,311,741 | |
| Net assets | £25,343,726 | £22,837,858 | |
| Equity | £25,343,726 | £22,837,858 | |
| Average employees | 10 | 7 | |
| Wages | £2,444,400 | £4,162,060 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 67.3% | -8.7% | |
| Net margin | -19.3% | -14.8% | |
| Return on capital employed | 50.1% | -2.9% | |
| Gearing (liabilities / total assets) | 62.8% | 63.2% | |
| Current ratio | 3.66x | 4.44x | |
| Interest cover | 8.97x | -0.48x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Frazier & Deeter (UK Audit) LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the Directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the parent Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- OAK HILL BIO LTD · parent
- OHB Neonatology Ltd 100%
- OHB DME Ltd 100%
- SuppreMol GmbH 100%
- Oak Hill Bio Corp 100%
- OHB Pediatrics Ltd 100%
Significant events
- “On 16 September 2024, the Company acquired the entire share capital of OHB Pediatrics Ltd for $0.01.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
8 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-01-10 | — | — |
| AL-MOSSAWI, Mohammad Hussein, Dr. | Director | 2024-08-11 | Nov 1981 | British |
| COLPMAN, David | Director | 2022-02-18 | Oct 1961 | British |
| DAVIS, Kim | Director | 2024-03-21 | Sep 1967 | American |
| DISTLER, Josh | Director | 2021-11-17 | Jul 1975 | American |
| GU, Jiaping, Dr. | Director | 2024-08-06 | Aug 1982 | American |
| MCHALE, Mark | Director | 2021-11-16 | Feb 1965 | British |
| THIARA, Parvinder | Director | 2026-01-26 | Aug 1985 | American |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALI, Tauhid | Director | 2022-05-13 | 2024-03-21 |
| BORADE, Shashibhushan Prataprao | Director | 2024-01-24 | 2024-09-26 |
| CURRAN, Daniel | Director | 2022-02-18 | 2024-03-21 |
| FARID, Ramy | Director | 2022-02-18 | 2024-01-24 |
| MANN, Sacha | Director | 2024-03-21 | 2024-08-06 |
| MOSES, Edwin, Dr | Director | 2022-03-23 | 2022-05-13 |
| NIKLAS, Victoria, Dr. | Director | 2022-02-18 | 2022-03-23 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Shashibhushan Prataprao Borade | Individual | Significant influence | 2022-12-27 | Ceased 2026-02-16 |
| Oliver Jacob Levy | Individual | Significant influence | 2022-01-24 | Ceased 2022-12-27 |
| Mr Josh Distler | Individual | Shares 50–75%, Voting 50–75% | 2022-01-14 | Ceased 2022-01-24 |
| Mark Mchale | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-11-16 | Ceased 2022-01-14 |
Filing timeline
Last 20 of 57 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-02-25 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-07 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2026-05-07 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-04-28 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-25 | RESOLUTIONS | resolution | Resolution | |
| 2026-02-18 | SH01 | capital | Capital allotment shares | |
| 2026-01-06 | SH01 | capital | Capital allotment shares | |
| 2025-11-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-01 | AA | accounts | Accounts with accounts type group | |
| 2024-12-04 | AA | accounts | Accounts with accounts type group | |
| 2024-11-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-10 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-20 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-20 | AP01 | officers | Appoint person director company with name date | |
| 2024-08-20 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-25 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-25 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-25 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-25 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-30 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-30 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 2
- Officers appointed
- 1
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-57.2%
£40,633,180 £17,382,260
-
Cash
-7.9%
£32,813,193 £30,233,448
-
Net assets
-9.9%
£25,343,726 £22,837,858
-
Employees
-30%
10 7
-
Operating profit
-105.5%
£27,328,022 -£1,510,528
-
Profit before tax
+43.1%
-£5,280,246 -£3,007,060
-
Wages
+70.3%
£2,444,400 £4,162,060
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers